Carla Fiankan
General Counsel bei ADVERUM BIOTECHNOLOGIES, INC.
Profil
Carla Fiankan's current job(s) include Vice President-Regulatory at InterMune, Inc. and Vice President-Regulatory Affairs at Adverum Biotechnologies, Inc. Ms. Fiankan's former job was as Associate Director-Regulatory Affairs at Gilead Sciences, Inc. from 2003 to 2010.
Ms. Fiankan's education history includes an undergraduate degree from Notre Dame de Namur University in 1990 and a graduate degree from San Jose State University in 1993.
Aktive Positionen von Carla Fiankan
| Unternehmen | Position | Beginn |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | General Counsel | - |
| INTERMUNE INC | General Counsel | 01.08.2011 |
Ehemalige bekannte Positionen von Carla Fiankan
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | General Counsel | 01.12.2010 |
Ausbildung von Carla Fiankan
| Notre Dame de Namur University | Undergraduate Degree |
| San Jose State University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
